<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id><journal-title>Environmental Health Perspectives</journal-title><issn pub-type="ppub">0091-6765</issn><publisher><publisher-name>National Institute of Environmental Health Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1289/ehp.10289</article-id><article-id pub-id-type="publisher-id">ehp0115-001557</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Protective Role of Matrix Metalloproteinase-9 in Ozone-Induced Airway Inflammation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>Hyoung-Kyu</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001557">1</xref><xref ref-type="aff" rid="af2-ehp0115-001557">2</xref></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Hye-Youn</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001557">1</xref></contrib><contrib contrib-type="author"><name><surname>Kleeberger</surname><given-names>Steven R.</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001557">1</xref><xref ref-type="corresp" rid="c1-ehp0115-001557"/></contrib></contrib-group><aff id="af1-ehp0115-001557"><label>1</label> Laboratory of Respiratory Biology, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA</aff><aff id="af2-ehp0115-001557"><label>2</label> Division of Pulmonary and Critical Care, Department of Internal Medicine, College of Medicine, Catholic University of Korea, Seoul, Korea</aff><author-notes><corresp id="c1-ehp0115-001557">Address correspondence to S.R. Kleeberger, Laboratory of Respiratory Biology, NIEHS, National Institutes of Health, 111 T.W. Alexander Dr., Bldg. 101, MD D-201, Research Triangle Park, NC 27709 USA. Telephone: (919) 541-3540. Fax: (919) 541-4133. E-mail: <email>kleeber1@niehs.nih.gov</email></corresp><fn><p>The authors declare they have no competing financial interests.</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>24</day><month>8</month><year>2007</year></pub-date><volume>115</volume><issue>11</issue><fpage>1557</fpage><lpage>1563</lpage><history><date date-type="received"><day>21</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2007</year></date></history><copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement><copyright-year>2007</copyright-year><abstract><sec><title>Background</title><p>Exposure to ozone causes airway inflammation, hyperreactivity, lung hyper-permeability, and epithelial cell injury. An early inflammatory response induced by inhaled O<sub>3</sub> is characterized primarily by release of inflammatory mediators such as cytokines, chemokines, and airway neutrophil accumulation. Matrix metalloproteinases (MMPs) have been implicated in the pathogenesis of oxidative lung disorders including acute lung injury, asthma, and chronic obstructive pulmonary disease.</p></sec><sec><title>Objective</title><p>We hypothesized that MMPs have an important role in the pathogenesis of O<sub>3</sub>-induced airway inflammation.</p></sec><sec sec-type="methods"><title>Methods</title><p>We compared the lung injury responses in either <italic>Mmp7</italic>- (<italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup>) or <italic>Mmp9</italic>-deficient (<italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup><italic>)</italic> mice and their wild-type controls (<italic>Mmp7</italic><italic><sup>+/+</sup></italic><italic>, Mmp9</italic><italic><sup>+/+</sup></italic><italic>)</italic> after exposure to 0.3 ppm O<sub>3</sub> or filtered air.</p></sec><sec><title>Results</title><p>Relative to air-exposed controls, MMP-9 activity in bronchoalveolar lavage fluid (BALF) was significantly increased by O<sub>3</sub> exposure in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice. O<sub>3</sub>-induced increases in the concentration of total protein (a marker of lung permeability) and the numbers of neutrophils and epithelial cells in BALF were significantly greater in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice compared with <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice. Keratinocyte-derived chemokine (KC) and macrophage inflammatory protein (MIP)-2 levels in BALF were also significantly higher in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice than in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice after O<sub>3</sub> exposure, although no differences in mRNA expression for these chemokines were found between genotypes. Mean BALF protein concentration and numbers of inflammatory cells were not significantly different between <italic>Mmp7</italic><italic><sup>+/+</sup></italic> and <italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup> mice after O<sub>3</sub> exposure.</p></sec><sec><title>Conclusions</title><p>Results demonstrated a protective role of MMP-9 but not of MMP-7, in O<sub>3</sub>-induced lung neutrophilic inflammation and hyperpermeability. The mechanism through which <italic>Mmp9</italic> limits O<sub>3</sub>-induced airway injury is not known but may be via posttranscriptional effects on proinflammatory CXC chemokines including KC and MIP-2.</p></sec></abstract><kwd-group><kwd>chemokine</kwd><kwd>knockout mice</kwd><kwd>lung</kwd><kwd>MMP-9</kwd><kwd>O<sub>3</sub></kwd><kwd>oxidant</kwd></kwd-group></article-meta></front><body><p>Ozone is a common urban air pollutant that remains a major health concern. Epidemiologic studies have demonstrated a strong association between high ambient O<sub>3</sub> concentration with cardiovascular and respiratory morbidity and mortality (<xref ref-type="bibr" rid="b5-ehp0115-001557">Bell et al. 2005</xref>). O<sub>3</sub> exposure elicits airway inflammation characterized by neutrophil accumulation (<xref ref-type="bibr" rid="b46-ehp0115-001557">Schelegle et al. 1991</xref>; <xref ref-type="bibr" rid="b48-ehp0115-001557">Seltzer et al. 1986</xref>) and liberates multiple inflammatory mediators, cytokines, and chemokines as an early inflammatory event (<xref ref-type="bibr" rid="b2-ehp0115-001557">Aris et al. 1993</xref>; <xref ref-type="bibr" rid="b28-ehp0115-001557">Koren et al. 1989</xref>). O<sub>3</sub>-induced activation of airway neutrophilic infiltration is likely to produce additional damage through the release of reactive oxygen species and endogenous proteolytic enzymes.</p><p>Several different kinds of endogenous proteases participate in the pathogenesis of airway inflammation. Among these, matrix metalloproteinases (MMPs) belong to a family of zinc-dependent extracellular enzymes that share common structural features and have an important role in many physiological and pathological conditions (<xref ref-type="bibr" rid="b42-ehp0115-001557">Parks and Shapiro 2001</xref>). MMPs are secreted by inflammatory and noninflammatory cells and have a major role in extracellular matrix (ECM) degradation, proteolytic modulation of biologically active proteins, and cell migration (<xref ref-type="bibr" rid="b20-ehp0115-001557">Goetzl et al. 1996</xref>; <xref ref-type="bibr" rid="b23-ehp0115-001557">Kelly et al. 2000</xref>; <xref ref-type="bibr" rid="b25-ehp0115-001557">Kheradmand et al. 2002</xref>; <xref ref-type="bibr" rid="b36-ehp0115-001557">Mautino et al. 1997</xref>; <xref ref-type="bibr" rid="b42-ehp0115-001557">Parks and Shapiro 2001</xref>). Elevated levels of MMPs are prominent in inflammatory disorders of the airway and parenchymal lung disease and have been also implicated in several pulmonary diseases characterized by lung tissue damage, alveolar structure alterations, or abnormal repair (<xref ref-type="bibr" rid="b18-ehp0115-001557">Elkington and Friedland 2006</xref>; <xref ref-type="bibr" rid="b42-ehp0115-001557">Parks and Shapiro 2001</xref>). MMPs can be divided on the basis of their substrate specificity into collagenases (MMP-1, 8, 13), gelatinases (MMP-2, 9), stromelysins (MMP-3, 10, 11), matrilysin (MMP-7), macrophage metalloelastase (MMP-12), and membrane-type (MT)-MMPs (MMP-14, 15, 16, 17) (<xref ref-type="bibr" rid="b53-ehp0115-001557">Visse and Nagase 2003</xref>).</p><p>Gelatinases degrade many ECM proteins; most important is type IV collagen, a major constituent of lung basement membrane (<xref ref-type="bibr" rid="b40-ehp0115-001557">Nagase and Woessner 1999</xref>). Therefore, gelatinases have been thought to have an important role in the pathogenesis of various lung diseases (<xref ref-type="bibr" rid="b40-ehp0115-001557">Nagase and Woessner 1999</xref>). Gelatinases also can cleave a variety of non-ECM proteins, including cytokines and chemokines (<xref ref-type="bibr" rid="b37-ehp0115-001557">McQuibban et al. 2000</xref>; <xref ref-type="bibr" rid="b55-ehp0115-001557">Yu and Stamenkovic 2000</xref>; <xref ref-type="bibr" rid="b56-ehp0115-001557">Zhang et al. 2003</xref>). MMP-2 (gelatinase A) is produced by a wide range of cell types in the lung, and it is increased in lung disorders with oxidative stress and inflammation etiologies (e.g., <xref ref-type="bibr" rid="b41-ehp0115-001557">Pardo et al. 1998</xref>; <xref ref-type="bibr" rid="b44-ehp0115-001557">Perez-Ramos et al. 1999</xref>; <xref ref-type="bibr" rid="b50-ehp0115-001557">Tan et al. 2006</xref>). MMP-9 (gelatinase B) has been implicated in the pathogenesis of asthma (<xref ref-type="bibr" rid="b8-ehp0115-001557">Cataldo et al. 2000</xref>), idiopathic pulmonary fibrosis (<xref ref-type="bibr" rid="b19-ehp0115-001557">Fukuda et al. 1998</xref>), chronic obstructive pulmonary disease (COPD; <xref ref-type="bibr" rid="b45-ehp0115-001557">Russell et al. 2002</xref>), and acute lung injury (<xref ref-type="bibr" rid="b30-ehp0115-001557">Lanchou et al. 2003</xref>). In the normal lung, constitutive expression of MMP-9 is restricted to neutrophils and eosinophils. However, MMP-9 induced by inflammatory stimuli and proinflammatory cytokines is generated in multiple cell types including alveolar macrophages and other resident pulmonary cells (<xref ref-type="bibr" rid="b4-ehp0115-001557">Atkinson and Senior 2003</xref>; <xref ref-type="bibr" rid="b9-ehp0115-001557">Chakrabarti and Patel 2005</xref>). MMP-9 is known to be induced by O<sub>3</sub> in murine skin and lung (<xref ref-type="bibr" rid="b24-ehp0115-001557">Kenyon et al. 2002</xref>; <xref ref-type="bibr" rid="b51-ehp0115-001557">Valacchi et al. 2003</xref>).</p><p>MMP-7 has homeostatic function and a role in innate immunity in epithelial cells (<xref ref-type="bibr" rid="b42-ehp0115-001557">Parks and Shapiro 2001</xref>). In adult human lung, MMP-7 is expressed by epithelial cells lining peribronchial and conducting airway (<xref ref-type="bibr" rid="b17-ehp0115-001557">Dunsmore et al. 1998</xref>). Increased expression of MMP-7 has been observed in airway and alveolar cells at sites of lung cancer (<xref ref-type="bibr" rid="b54-ehp0115-001557">Wilson and Matrisian 1996</xref>), idiopathic pulmonary fibrosis (<xref ref-type="bibr" rid="b57-ehp0115-001557">Zuo et al. 2002</xref>), and cystic fibrosis (<xref ref-type="bibr" rid="b17-ehp0115-001557">Dunsmore et al. 1998</xref>). Although it is clear that MMP-7 is associated with chronic lung disease, the role of MMP-7 in O<sub>3</sub>-induced airway inflammation is still unknown.</p><p>In the present studies, we hypothesized that murine MMP-7 and MMP-9 have important functional roles in facilitating the airway inflammatory responses induced by inhaled O<sub>3</sub>. To address this hypothesis, we used mice genetically deficient in <italic>Mmp7</italic> (Mmp7, matrix metalloproteinase 7; Entrez Gene ID 17393, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene">http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene</ext-link>) and <italic>Mmp9</italic> (Mmp9; matrix metalloproteinase 9; Entrez Gene ID 17395, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene">http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene</ext-link>) and compared airway injury responses with O<sub>3</sub> relative to corresponding wild-type control mice.</p><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Animals and inhalation exposure</title><p>Male (6&#x02013;8 weeks old, 20&#x02013;25 g) C57BL/6J (<italic>Mmp7</italic><italic><sup>+/+</sup></italic>) and B6.129-<italic>Mmp7</italic><italic><sup>tm1Lmm</sup></italic>/J (<italic>Mmp7</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup>), FVB/NJ (<italic>Mmp9</italic><italic><sup>+/+</sup></italic>), and FVB.Cg-<italic>Mmp9</italic><italic><sup>tm1Tvu</sup></italic>/J (<italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup>) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Inhalation exposures were performed in a barrier facility at Alion Science and Technology, Inc. (Research Triangle Park, NC). After acclimation, mice were placed in individual stainless-steel wire cages within a Hazelton 1000 chamber (Lab Products, Maywood, NJ) equipped with a charcoal and high-efficiency particulate air-filtered air supply. Mice had free access to water and pelleted open-formula rodent diet NIH-31 (Zeigler Bros, Inc., Gardners, PA). Mice were exposed continuously to 0.3 ppm O<sub>3</sub> for 6, 24, 48, or 72 hr. O<sub>3</sub> was generated from ultra-high purity air (&#x0003c; 1 ppm total hydrocarbons; National Welders, Inc., Raleigh, NC) using a silent arc discharge O<sub>3</sub> generator (Model L-11; Pacific Ozone Technology, Benecia, CA). Constant chamber air temperature (72 &#x000b1; 3&#x000b0;F) and relative humidity (50 &#x000b1; 15%) were maintained. O<sub>3</sub> concentration was continually monitored (Dasibi model 1008-PC, Dasabi Environmental Corp., Glendale, CA). Parallel exposure to filtered air was conducted in a separate chamber for 48 hr. All animal use was approved by the National Institute of Environmental Health Sciences Animal Care and Use Committee, and all animals were treated humanely and with regard for alleviation of suffering.</p></sec><sec><title>Lung bronchoalveolar lavage fluid (BALF) and cell preparation</title><p>Immediately after exposure to air or O<sub>3</sub>, mice were euthanized with sodium pentobarbital (104 mg/kg). After 24-or 48-hr exposure, BAL was performed <italic>in situ</italic> 4 times with Hanks balanced salt solution (35 mL/kg; pH 7.2&#x02013;7.4). These time points were chosen for BAL procedures on the basis of previous investigations with multiple inbred strains of mice that indicated inflammation and injury peaked between 24 and 48 hr during continuous exposure to 0.3 ppm O<sub>3</sub> (e.g., <xref ref-type="bibr" rid="b11-ehp0115-001557">Cho et al. 2007</xref>; <xref ref-type="bibr" rid="b14-ehp0115-001557">Dahl et al. 2007</xref>; <xref ref-type="bibr" rid="b26-ehp0115-001557">Kleeberger et al. 1993</xref>). Recovered BALF was immediately cooled in ice and centrifuged (1,000 &#x000d7; <italic>g</italic>, 10 min). The cell pellets were resuspended in 1 mL of Hanks balanced salt solution, and the cells were counted with a hemacytometer. Aliquots (150 &#x003bc;L) were cyto-centrifuged, and the cells were stained with Wright-Giemsa stain solutions (Fisher Scientific, Pittsburgh, PA) for differential cell analysis (markers of cellular inflammation and epithelial injury). The supernatants from the first BALF return were assayed for total protein (a marker of lung permeability) with the Bradford assay (<xref ref-type="bibr" rid="b7-ehp0115-001557">Bradford 1976</xref>).</p></sec><sec><title>Lung tissue preparation for histopathology and immunohistochemistry</title><p>Left lung lobes from mice exposed to either 0.3 ppm O<sub>3</sub> or filtered air for 48 hr were inflated gently with zinc formalin, fixed at a constant pressure (25 cm) of the same fixative for 30 min, tied off at the trachea, and immersed in the fixative for 1 day. Proximal and distal intrapulmonary axial airway was excised, embedded in paraffin, and sectioned (5 &#x003bc;m). Tissue sections were histochemically stained with hematoxylin and eosin (H&#x00026;E) for morphological comparison of pulmonary injury between genotypes. The terminal bronchioles and alveoli were the primary focus of study because 48-hr exposure to 0.3 ppm O<sub>3</sub> causes histologically evident inflammation and epithelial lesions in these regions of the mouse lung. Separate tissue sections from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> or <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice were immunologically stained using a goat anti-mouse MMP-9 antibody (R&#x00026;D Systems, Inc., Minneapolis, MN) or a rat anti-mouse Ki-67 antibody (Dako North American, Inc., Carpinteria, CA) to localize MMP-9 and Ki-67, respectively, using the standard peroxidase&#x02013;diaminobenzidine (DAB) method.</p></sec><sec sec-type="methods"><title>Western blot analysis</title><p>Equal amounts of total lung protein (45 &#x003bc;g) isolated from mouse lung homogenates (air or 24, 48, and 72 hr of O<sub>3</sub>) in radioimmunoprecipitation (RIPA) buffer (1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 10 g phenylmethylsulfonyl fluoride/mL, 1 mM sodium orthovanadate, 1&#x000d7; protease inhibitor cocktail in 1&#x000d7; phosphate-buffered saline) were separated on 10&#x02013;20% SDS gel electrophoresis gels. The 24-, 48-, and 72-hr time points were chosen for investigation to characterize the kinetics of lung MMP activity changes induced by O<sub>3</sub> exposure. Proteins were then transferred to a polyvinylidene fluoride (PVDF) membrane. The membrane was blocked for 2 hr at room temperature with 5% nonfat milk in Tris-buffered saline&#x02013;Tween buffer (20 mmol/L Tris, 500 mmol/L NaCl, 0.01% Tween 20). The blot was then incubated at 4&#x000b0;C overnight with anti-MMP-9 (R&#x00026;D Systems), anti-MMP-2 (R&#x00026;D Systems), or an anti-actin antibody (SantaCruz Biotechnology Inc., Santa Cruz, CA) as an internal control, followed by incubation for 1&#x02013;2 hr with the proper secondary horseradish peroxidase-conjugated antibodies. The immunoblot was visualized through enhanced chemiluminescence.</p></sec><sec><title>Total RNA isolation and real-time quantitative reverse transcriptase&#x02013;polymerase chain reaction (RT-PCR)</title><p>Total RNA from frozen lungs (air or 6, 24, and 48 hr of O<sub>3</sub>) was isolated using the RNeasy Midiprep kit (QIA-GEN, Valencia, CA). The 6-hr time point was included in this protocol to optimize the likelihood of capturing early inflammatory cytokine/chemokine gene expression on the basis of previous experience with this model (<xref ref-type="bibr" rid="b11-ehp0115-001557">Cho et al. 2007</xref>). One microgram total RNA was reverse transcribed into cDNA in a volume of 50 &#x003bc;L containing 1&#x000d7; PCR buffer [50 mM KCl and 10 mM Tris (pH 8.3)], 5 mM MgCl<sub>2</sub>, 1 mM each dNTPs, 125 ng oligo (dT)<sub>15</sub>, and 50 U of Moloney murine leukemia virus reverse transcriptase (Invitrogen Life Technologies, Carlsbad, CA), at 45&#x000b0;C for 15 min and 95&#x000b0;C for 5 min using the Gene Amp PCR System 9700 (Applied Biosystems, Foster City, CA).</p><p>An aliquot (2&#x02013;5 &#x003bc;L) of the reverse transcriptase product (equivalent to 40&#x02013;100 ng RNA) was amplified using PowerSYBR gene expression assays on the 7700 Prism sequence detection system (Applied Biosystems). The PCR conditions and data analysis were performed according to the manufacturer&#x02019;s protocol in User Bulletin no. 2, &#x0201c;Applied Biosystems Prism 7700 Sequence Detection System&#x0201d; (<xref ref-type="bibr" rid="b1-ehp0115-001557">Applied Biosystems 2007</xref>). Quantification of gene expression was determined by the number of cycles to threshold (C<sub>T</sub>) of fluorescence detection. Relative gene expression was determined using the comparative C<sub>T</sub> method as described previously (<xref ref-type="bibr" rid="b9-ehp0115-001557">Chakrabarti and Patel 2005</xref>). Briefly, the &#x00394;C<sub>T</sub> value was obtained by subtracting the 18s rRNA C<sub>T</sub> value from the C<sub>T</sub> value of the gene tested in the same sample. Message levels of each gene were expressed as fold changes relative to those in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> air controls.</p></sec><sec sec-type="methods"><title>Gelatin zymography analysis</title><p>Equal volumes of BALF (10 &#x003bc;L) samples were loaded on 10% Tris&#x02013;glycine gel with 0.1% gelatin (Invitrogen Life Technologies) for electrophoresis. To eliminate the SDS content, the gels were washed with 2.7% (wt/vol) Triton X-100 at room temperature for 30 min and incubated for 16 hr in a buffer containing 50 mM Tris base, 40 mM HCl, 200 mM NaCl, 5 mM CaCl<sub>2</sub>, and 0.02% (wt/vol) Brij 35 for gelatinolytic enzymes to act. The digested gels were stained in Colloidal Blue Staining kit (Bio-Rad Laboratories, Hercules, CA) for 4 hr to visualize the gelatin activity. Gelatinolytic bands were analyzed by a Gel Doc 2000 System (Bio-Rad).</p></sec><sec><title>Cytokine enzyme-linked immunosorbent assay (ELISA)</title><p>Immunoreactive macrophage inflammatory protein-2 [MIP-2, human interleukin-8 (IL-8) analogue, similar to chemokine (C-X-C motif) ligand (CXCL) 1 and 2] and keratinocyte-derived chemokine [KC, human growth-regulated oncogene (GRO)-&#x003b1; analogue, similar to CXCL1, 2, and 3] were quantified in aliquots of BALF (50 &#x003bc;L) using commercially available ELISA kits (R&#x00026;D Systems), according to the manufacturer&#x02019;s instructions. Each cytokine quantity was calculated from absorbance at 450 nm using a standard curve.</p></sec><sec sec-type="results"><title>Statistics</title><p>All data are expressed as group means &#x000b1; SE. Two-way analysis of variance (ANOVA) was used to evaluate the effects of subacute O<sub>3</sub> exposure on lung injury parameters between <italic>Mmp7</italic><italic><sup>+/+</sup></italic> and <italic>Mmp7</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> or <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice. The factors in the analysis were exposure (air vs. O<sub>3</sub>) and genotype (<italic>Mmp7</italic><italic><sup>+/+</sup></italic> vs. <italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup><italic>, Mmp9</italic><italic><sup>+/+</sup></italic> vs. <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup>). The dependent variables were protein level, cell number, MMP-2 activity, and cytokine concentrations in BALF, and lung protein and mRNA levels. One-way ANOVA was used to evaluate the effect of O<sub>3</sub> on MMP-9 production and expression in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice. The Student&#x02013;Newman&#x02013;Keuls test was used for <italic>a posteriori</italic> comparisons of means. All analyses were performed using a commercial statistical analysis package (SigmaStat; SPSS Inc., Chicago, IL). Statistical significance was accepted at <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Roles of MMP-7 and MMP-9 in O<sub>3</sub>-induced airway inflammation</title><p>The roles of MMP-7 and MMP-9 in O<sub>3</sub>-induced airway inflammation were assessed by exposing <italic>Mmp7</italic><italic><sup>+/+</sup></italic><italic>, Mmp7</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup><italic>, Mmp9</italic><italic><sup>+/+</sup></italic><italic>,</italic> and <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice continuously to air or O<sub>3</sub> for 24 and 48 hr. No significant differences in mean BAL protein concentration or cell numbers were found between respective +/+ and &#x02212;<italic>/</italic>&#x02212; genotypes after exposure to air (<xref ref-type="fig" rid="f1-ehp0115-001557">Figure 1</xref>, <xref ref-type="table" rid="t1-ehp0115-001557">Table 1</xref>). After 48 hr of O<sub>3</sub> exposure, BAL protein concentration was significantly (<italic>p</italic> &#x0003c; 0.05) increased in all four genotypes (<xref ref-type="fig" rid="f1-ehp0115-001557">Figure 1</xref>, <xref ref-type="table" rid="t1-ehp0115-001557">Table 1</xref>). The BALF protein concentration was significantly greater (68%) in <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice compared with <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="f1-ehp0115-001557">Figure 1A</xref>); however, no significant differences in protein concentration were found between <italic>Mmp7</italic><italic><sup>+/+</sup></italic> and <italic>Mmp7</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice after exposure to O<sub>3</sub> (<xref ref-type="table" rid="t1-ehp0115-001557">Table 1</xref>). O<sub>3</sub> caused significant increases in the mean numbers of BAL neutrophils in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice after 48 hr of O<sub>3</sub> exposure (<italic>p</italic> &#x0003c; 0.05; <xref ref-type="fig" rid="f1-ehp0115-001557">Figure 1B</xref>). However, compared with <italic>Mmp9</italic><sup>+/+</sup> mice, O<sub>3</sub>-enhanced BAL neutrophil numbers were significantly higher in <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup>mice (<italic>p</italic> &#x0003c; 0.05). Mean numbers of epithelial cells were also significantly greater in <italic>Mmp</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice relative to those in <italic>Mmp</italic><italic><sup>+/+</sup></italic> mice after 24- and 48-hr O<sub>3</sub> exposure (<italic>p</italic> &#x0003c; 0.05; <xref ref-type="fig" rid="f1-ehp0115-001557">Figure 1C</xref>). No significant differences in the number of BALF alveolar macrophages were found between <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice (data not shown). No significant differences in mean numbers of BALF inflammatory cells were found between <italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Mmp7</italic><italic><sup>+/+</sup></italic> mice after exposure to O<sub>3</sub> (<xref ref-type="table" rid="t1-ehp0115-001557">Table 1</xref>).</p></sec><sec><title>Effect of O<sub>3</sub> on MMP-2 and MMP-9 expression in the lung</title><p>We performed gelatin zymogram and Western blot analyses on BALF and lung protein extracts from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice to determine whether production of MMP-2 and MMP-9 was augmented by O<sub>3</sub> exposure. Both gelatinases have been implicated in the pathogenesis of inflammation-related lung diseases (e.g., <xref ref-type="bibr" rid="b41-ehp0115-001557">Pardo et al. 1998</xref>; <xref ref-type="bibr" rid="b50-ehp0115-001557">Tan et al. 2006</xref>); we also reasoned that MMP-2 expression might be enhanced to compensate for MMP-9 deletion. Minimal gelatinase activity was found in BALF from either genotype after air exposure. Exposure to O<sub>3</sub> (48 and 72 hr) caused significant (<italic>p</italic> &#x0003c; 0.05) increase in MMP-9 activity at 92 kDa (latent form) and 88 kDa (active form) in BALF from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="f2-ehp0115-001557">Figure 2A</xref>). Western blot analyses confirmed O<sub>3</sub>-induced increase in MMP-9 protein levels in lung homogenates from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="f2-ehp0115-001557">Figure 2B</xref>). Furthermore, lung MMP-9 mRNA expression in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice was significantly increased compared with air controls after 6 hr of O<sub>3</sub> and remained increased by 48-hr exposure (<italic>p</italic> &#x0003c; 0.05; <xref ref-type="fig" rid="f2-ehp0115-001557">Figure 2C</xref>). MMP-9 proteins were localized primarily in alveolar epithelial cells, infiltrating inflammatory cells, endothelial cells, and cells in the injured parenchyma of <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice after O<sub>3</sub> exposure (<xref ref-type="fig" rid="f3-ehp0115-001557">Figure 3</xref>).</p><p>Basal levels of MMP-2 protein and activity were detectable in lung protein extract and BALF, respectively, from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice, although no differences were detected between genotypes. O<sub>3</sub> increased MMP-2 activity and production in both genotypes compared with corresponding baseline (<xref ref-type="fig" rid="f4-ehp0115-001557">Figure 4A,B</xref>), but the increases were significantly (<italic>p</italic> &#x0003c; 0.05) greater in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> compared with <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice.</p></sec><sec><title><italic>Effects of</italic> Mmp9 <italic>deficiency on O</italic><italic><sub>3</sub></italic><italic>-induced pulmonary pathology.</italic></title><p>H&#x00026;E-stained lung sections from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice exposed to air were normal, and no histological differences were found between them (<xref ref-type="fig" rid="f5-ehp0115-001557">Figure 5A,5C</xref>). After 48 hr of O<sub>3</sub> exposure, significant peribronchiolar inflammation and proliferation as well as epithelial hyperplasia in terminal bronchioles were detected in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="f5-ehp0115-001557">Figure 5B,D</xref>). However, O<sub>3</sub> caused more severe epithelial thickening, inflammation, and alveolar vacuolization in the terminal bronchioles of <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> compared with <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="f5-ehp0115-001557">Figure 5D</xref>). Enhanced airway cellular proliferation was also more severe in the absence of MMP-9 as determined by immunohistochemistry of Ki-67&#x02013;positive cells in G/S phases of the cell cycle (<xref ref-type="fig" rid="f6-ehp0115-001557">Figure 6</xref>). Nuclear localization of Ki-67 was mainly found in inflammatory cells and in cells of the terminal bronchioles that were injured by O<sub>3</sub>.</p></sec><sec><title><italic>Effect of</italic> Mmp9 <italic>deficiency on protein levels and mRNA expression of the neutrophil chemokines KC and MIP-2.</italic></title><p>To investigate the mechanism for increased neutrophil recruitment to the airway in the absence of MMP-9, we used ELISA to measure BALF levels of chemokines known to be involved in neutrophil chemotaxis (KC and MIP-2). No significant genotype-specific differences in mean concentrations of KC or MIP-2 were found after exposure to air (<xref ref-type="fig" rid="f7-ehp0115-001557">Figure 7</xref>). Mean KC and MIP-2 concentrations were significantly increased in BALF by O<sub>3</sub> exposure in both genotypes (<italic>p</italic> &#x0003c; 0.05, <xref ref-type="fig" rid="f7-ehp0115-001557">Figure 7</xref>). However, consistent with BALF inflammatory parameters and pathology (<xref ref-type="fig" rid="f1-ehp0115-001557">Figures 1</xref>, <xref ref-type="fig" rid="f5-ehp0115-001557">5</xref>, and <xref ref-type="fig" rid="f6-ehp0115-001557">6</xref>), KC and MIP-2 levels were significantly (<italic>p</italic> &#x0003c; 0.05) greater in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice compared with <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice after 24- and 48-hr exposure to O<sub>3</sub> (<xref ref-type="fig" rid="f7-ehp0115-001557">Figure 7</xref>). KC and MIP-2 mRNA levels were not different between genotypes after exposure to air. After 24- and 48-hr exposure to O<sub>3</sub>, KC and MIP-2 mRNA was increased significantly (<italic>p</italic> &#x0003c; 0.05) over the air controls in both genotypes but, interestingly, no differences were found between genotypes (<xref ref-type="fig" rid="f8-ehp0115-001557">Figure 8</xref>).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>O<sub>3</sub>-induced airway inflammation is characterized by early neutrophilic infiltration followed by a mononuclear cell dominated inflammation (<xref ref-type="bibr" rid="b10-ehp0115-001557">Chitano et al. 1995</xref>). Molecular changes during the pulmonary pathogenesis induced by O<sub>3</sub> include increased production of prostaglandins, proinflammatory cytokines, and chemokines such as IL-6, IL-8, granulocyte macrophage colony-stimulating factor, KC, and MIP-2 (<xref ref-type="bibr" rid="b16-ehp0115-001557">Devlin et al. 1991</xref>; <xref ref-type="bibr" rid="b21-ehp0115-001557">Johnston et al. 2005a</xref>). In humans, neutrophil influx begins in peripheral airways as early as 6 hr after O<sub>3</sub> exposure and is known to be mediated by neutrophilic chemokines such as IL-8 and GRO-&#x003b1; (<xref ref-type="bibr" rid="b29-ehp0115-001557">Krishna et al. 1998</xref>). Functional roles of several inflammatory mediators such as tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) (Cho et al. 2001; <xref ref-type="bibr" rid="b27-ehp0115-001557">Kleeberger et al. 1997</xref>), IL-6 (<xref ref-type="bibr" rid="b22-ehp0115-001557">Johnston et al. 2005b</xref>), and IL-1&#x003b2; (<xref ref-type="bibr" rid="b3-ehp0115-001557">Arsalane et al. 1995</xref>), and the transcription factors nuclear factor kappa B (<xref ref-type="bibr" rid="b11-ehp0115-001557">Cho et al. 2007</xref>; <xref ref-type="bibr" rid="b32-ehp0115-001557">Laskin et al. 2002</xref>) and activator protein (AP)-1 (<xref ref-type="bibr" rid="b11-ehp0115-001557">Cho et al. 2007</xref>) have also been determined in pulmonary inflammation of laboratory rodents exposed to O<sub>3</sub>.</p><p>The primary functions of MMPs include degradation and turnover of ECM, tissue repair and remodeling, and leukocyte migration from peripheral circulation to inflammatory sites. Furthermore, recent findings suggested that MMPs can modulate inflammation and innate immunity by affecting the activity of various nonmatrix proteins (<xref ref-type="bibr" rid="b43-ehp0115-001557">Parks et al. 2004</xref>). MMP-9 has been thought to be particularly important in the pathogenesis of inflammatory lung diseases, including acute lung injury, asthma, and COPD (<xref ref-type="bibr" rid="b4-ehp0115-001557">Atkinson and Senior 2003</xref>). Higher than normal MMP-9 levels in the patients with these disorders may promote destruction of normal tissue architecture and increased migration of inflammatory cells to the disease sites (<xref ref-type="bibr" rid="b33-ehp0115-001557">Lemjabbar et al. 1999a</xref>, <xref ref-type="bibr" rid="b34-ehp0115-001557">1999b</xref>).</p><p>In the present study, we hypothesized that MMP-9 is essential for O<sub>3</sub>-induced airway inflammation because MMP-9 is one of the most predominant MMPs found in inflammatory airway diseases (<xref ref-type="bibr" rid="b4-ehp0115-001557">Atkinson and Senior 2003</xref>). Contrary to predictions, we found that O<sub>3</sub>-induced neutrophilic airway inflammation and injury were markedly increased in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice compared with <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice, indicating a protective role of MMP-9 in O<sub>3</sub>-exposed airways. The results from the current study suggest that MMP-9 may not act primarily on ECM degradation that facilitates leukocyte migration to pulmonary inflammatory sites as indicated by another investigation (<xref ref-type="bibr" rid="b6-ehp0115-001557">Betsuyaku et al. 1999</xref>). Heightened neutrophilic inflammation was also associated with enhanced levels of KC and MIP-2, which are important chemokines for neutrophil recruitment to the lung.</p><p>MMP-9 has diverse effects on neutrophilic inflammation in experimental animal models. It enhances neutrophil chemotaxis in response to certain chemokines (<xref ref-type="bibr" rid="b15-ehp0115-001557">D&#x02019;Haese et al. 2000</xref>) and increases neutrophil influx in glomerulonephritis (<xref ref-type="bibr" rid="b49-ehp0115-001557">Sternlicht and Werb 2001</xref>). Conversely, MMP-9 also has inhibitory effects on BALF neutrophilia (<xref ref-type="bibr" rid="b31-ehp0115-001557">Lanone et al. 2002</xref>); increased tissue neutrophil and inflammatory cell infiltration have been shown in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup>mice in response to epithelial injury and chemokine administration (<xref ref-type="bibr" rid="b15-ehp0115-001557">D&#x02019;Haese et al. 2000</xref>; <xref ref-type="bibr" rid="b39-ehp0115-001557">Mohan R et al. 2002</xref>). Several lines of molecular evidence have determined that proteolytic function of MMP-9 affects cytokine and chemokine levels as well as their activities. For example, MMP-9 processes and activates pro-IL-1&#x003b2; (<xref ref-type="bibr" rid="b47-ehp0115-001557">Schonbeck et al. 1998</xref>), inactive membrane bound forms of TNF-&#x003b1; (<xref ref-type="bibr" rid="b38-ehp0115-001557">Mohan MJ et al. 2002</xref>), and transforming growth factor-&#x003b2; (TGF-&#x003b2;) (<xref ref-type="bibr" rid="b55-ehp0115-001557">Yu and Stamenkovic 2000</xref>). MMP-9 also processes CXC chemokines, which exert potent chemoattractant activities on leukocytes and alters their specific activities, but not CC chemokines (e.g., RANTES and MCP-2) (<xref ref-type="bibr" rid="b52-ehp0115-001557">Van den Steen et al. 2000</xref>). MMP-9 truncates IL-8 (1&#x02013;77) into IL-8 (7&#x02013;77), which enhances neutrophil activation more than 10-fold (<xref ref-type="bibr" rid="b52-ehp0115-001557">Van den Steen et al. 2000</xref>). In contrast, neutrophilic chemoattractant activity was decreased by MMP-9 degradation of the other CXC chemokines GRO-&#x003b1; and connective tissue&#x02013;activating peptide (CTAP)-III (<xref ref-type="bibr" rid="b52-ehp0115-001557">Van den Steen et al. 2000</xref>). Our current observation that O<sub>3</sub> induced higher levels of BAL CXC chemokines KC and MIP-2 in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice than in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice is consistent with, but does not prove, the notion that these chemokines were key effectors of pulmonary MMP-9. Interestingly, we also found no differences in the steady state mRNA levels of the O<sub>3</sub>-increased KC and MIP-2 between <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice. Together these results suggest that differences in these chemokine levels in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice compared with those in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice were caused by translational or posttranslational processes, which may include degradation/cleavage by MMP-9.</p><p>Significantly greater elevation of MMP-2 level and activity were observed in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice compared with <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice after O<sub>3</sub> exposure. We cannot rule out the possibility that increased MMP-2 is a compensatory response in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice and may be involved in increased neutrophilic airway inflammation. However, MMP-9 has been reported to be the dominant airway MMP controlling inflammatory cell egression (<xref ref-type="bibr" rid="b12-ehp0115-001557">Corry et al. 2004</xref>), and there is no evidence that MMP-2 has a modulating effect on inflammatory chemokines such as KC and MIP-2 (<xref ref-type="bibr" rid="b43-ehp0115-001557">Parks et al. 2004</xref>). In addition, neutrophil concentrations in BALF were not changed in <italic>Mmp2</italic><sup>&#x02212;/&#x02212;</sup> mice in a model of allergic asthma (<xref ref-type="bibr" rid="b13-ehp0115-001557">Corry et al. 2002</xref>). We therefore postulate that MMP-2 does not have a critical role in heightened neutrophilic inflammation in <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice, although it may be involved with other mechanisms of lung injury induced by O<sub>3</sub> exposure (e.g., lung hyperpermeability).</p><p>The role of MMP-7 in acute lung injury has been studied in mouse models of interstitial pulmonary diseases such as fibrosis: <italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup> mice had suppressed pulmonary fibrosis caused by bleomycin (<xref ref-type="bibr" rid="b35-ehp0115-001557">Li et al. 2002</xref>; <xref ref-type="bibr" rid="b57-ehp0115-001557">Zuo et al. 2002</xref>), and it was accompanied by decreased neutrophilic inflammation and chemokines (e.g., KC) in the alveolar fluid (<xref ref-type="bibr" rid="b35-ehp0115-001557">Li et al. 2002</xref>). We predicted that O<sub>3</sub>-induced airway inflammation would be attenuated in <italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup> mice. However, the current findings suggest that MMP-7 is not significantly associated with O<sub>3</sub>-induced airway inflammation and injury in mice. In addition, KC concentrations in BALF were not significantly different between <italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Mmp7</italic><italic><sup>+/+</sup></italic> mice in the current model (data not shown). No studies have investigated the role of MMP-7 in oxidative lung injury such as O<sub>3</sub>. Different from MMP-9, matrilysin is produced by alveolar epithelial cells in injured lungs, and it has been thought to contribute to alveolar epithelial injury and re-epithelialization. Inhaled O<sub>3</sub> mostly affects centriacinar legions of the airway, but not alveoli, which may partially explain why MMP-7 deficiency failed to alter airway inflammation by O<sub>3</sub>.</p><p>In summary, our results showed that deficiency in MMP-9 was associated with enhanced airway epithelial injury, neutrophil recruitment, and permeability following O<sub>3</sub> exposure, but a deficiency in MMP-7 did not significantly affect O<sub>3</sub>-induced airway injury. The aberrant neutrophil recruitment was correlated with increased levels of KC and MIP-2 protein, but not mRNA expression, in the <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice relative to <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice. Results are consistent with the hypothesis that enhanced O<sub>3</sub>-induced injury in <italic>Mmp</italic><sup>&#x02212;/&#x02212;</sup> mice is related to a difference in posttranscriptional processing of these CXC chemokines in the airway. These findings increase our understanding of the pathophysiological process of O<sub>3</sub>-induced lung injury and suggest that MMP-9 produced in the lung in response to oxidative stimuli may have a beneficial function.</p></sec></body><back><fn-group><fn><p>The authors thank D. Morgan and H. Price for coordinating the inhalation exposures. D. Brass and D. Cook at the NIEHS provided excellent critical review of the manuscript.</p></fn><fn><p>This research was supported by the Intramural Research Program of the NIH, and NIEHS. Ozone exposures were conducted at the NIEHS Inhalation Facility under contract to Alion Science and Technology, Inc.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ehp0115-001557"><citation citation-type="book"><collab>Applied Biosystems</collab><year>2007</year><source>User Bulletin no. 2: Applied Biosystems Prism 7700 Sequence Detection System</source><publisher-loc>Foster City, CA</publisher-loc><publisher-name>Applied Biosystems</publisher-name><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_040980.pdf">http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_040980.pdf</ext-link></comment><access-date>[accessed 1 October 2007]</access-date></citation></ref><ref id="b2-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aris</surname><given-names>RM</given-names></name><name><surname>Christian</surname><given-names>D</given-names></name><name><surname>Hearne</surname><given-names>PQ</given-names></name><name><surname>Kerr</surname><given-names>K</given-names></name><name><surname>Finkbeiner</surname><given-names>WE</given-names></name><name><surname>Balmes</surname><given-names>JR</given-names></name></person-group><year>1993</year><article-title>Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy</article-title><source>Am Rev Respir Dis</source><volume>148</volume><issue>5</issue><fpage>1363</fpage><lpage>1372</lpage><pub-id pub-id-type="pmid">8239177</pub-id></citation></ref><ref id="b3-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arsalane</surname><given-names>K</given-names></name><name><surname>Gosset</surname><given-names>P</given-names></name><name><surname>Vanhee</surname><given-names>D</given-names></name><name><surname>Voisin</surname><given-names>C</given-names></name><name><surname>Hamid</surname><given-names>Q</given-names></name><name><surname>Tonnel</surname><given-names>AB</given-names></name><etal/></person-group><year>1995</year><article-title>Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro</article-title><source>Am J Respir Cell Mol Biol</source><volume>13</volume><issue>1</issue><fpage>60</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">7598938</pub-id></citation></ref><ref id="b4-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>JJ</given-names></name><name><surname>Senior</surname><given-names>RM</given-names></name></person-group><year>2003</year><article-title>Matrix metalloproteinase-9 in lung remodeling</article-title><source>Am J Respir Cell Mol Biol</source><volume>28</volume><issue>1</issue><fpage>12</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">12495928</pub-id></citation></ref><ref id="b5-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>ML</given-names></name><name><surname>Dominici</surname><given-names>F</given-names></name><name><surname>Samet</surname><given-names>JM</given-names></name></person-group><year>2005</year><article-title>A meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study</article-title><source>Epidemiology</source><volume>16</volume><issue>4</issue><fpage>436</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">15951661</pub-id></citation></ref><ref id="b6-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Betsuyaku</surname><given-names>T</given-names></name><name><surname>Shipley</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Senior</surname><given-names>RM</given-names></name></person-group><year>1999</year><article-title>Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B</article-title><source>Am J Respir Cell Mol Biol</source><volume>20</volume><issue>6</issue><fpage>1303</fpage><lpage>1309</lpage><pub-id pub-id-type="pmid">10340950</pub-id></citation></ref><ref id="b7-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group><year>1976</year><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title><source>Anal Biochem</source><volume>72</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">942051</pub-id></citation></ref><ref id="b8-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cataldo</surname><given-names>D</given-names></name><name><surname>Munaut</surname><given-names>C</given-names></name><name><surname>Noel</surname><given-names>A</given-names></name><name><surname>Frankenne</surname><given-names>F</given-names></name><name><surname>Bartsch</surname><given-names>P</given-names></name><name><surname>Foidart</surname><given-names>JM</given-names></name><etal/></person-group><year>2000</year><article-title>MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease</article-title><source>Int Arch Allergy Immunol</source><volume>123</volume><issue>3</issue><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">11112863</pub-id></citation></ref><ref id="b9-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>KD</given-names></name></person-group><year>2005</year><article-title>Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology</article-title><source>Exp Lung Res</source><volume>31</volume><issue>6</issue><fpage>599</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">16019990</pub-id></citation></ref><ref id="b10-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chitano</surname><given-names>P</given-names></name><name><surname>Hosselet</surname><given-names>JJ</given-names></name><name><surname>Mapp</surname><given-names>CE</given-names></name><name><surname>Fabbri</surname><given-names>LM</given-names></name></person-group><year>1995</year><article-title>Effect of oxidant air pollutants on the respiratory system: insights from experimental animal research</article-title><source>Eur Respir J</source><volume>8</volume><issue>8</issue><fpage>1357</fpage><lpage>1371</lpage><pub-id pub-id-type="pmid">7489804</pub-id></citation></ref><ref id="b11-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>HY</given-names></name><name><surname>Morgan</surname><given-names>D</given-names></name><name><surname>Bauer</surname><given-names>AK</given-names></name><name><surname>Kleeberger</surname><given-names>SR</given-names></name></person-group><year>2007</year><article-title>Signal trans-duction pathways of tumor necrosis factor-mediated lung injury induced by ozone in mice</article-title><source>Am J Respir Crit Care Med</source><volume>175</volume><issue>8</issue><fpage>829</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">17255564</pub-id></citation></ref><ref id="b12-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corry</surname><given-names>DB</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>LZ</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><etal/></person-group><year>2004</year><article-title>Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines</article-title><source>FASEB J</source><volume>18</volume><issue>9</issue><fpage>995</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">15059974</pub-id></citation></ref><ref id="b13-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corry</surname><given-names>DB</given-names></name><name><surname>Rishi</surname><given-names>K</given-names></name><name><surname>Kanellis</surname><given-names>J</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Song Lz</surname><given-names>LZ</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group><year>2002</year><article-title>Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency</article-title><source>Nat Immunol</source><volume>3</volume><issue>4</issue><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">11887181</pub-id></citation></ref><ref id="b14-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>M</given-names></name><name><surname>Bauer</surname><given-names>AK</given-names></name><name><surname>Arredouani</surname><given-names>M</given-names></name><name><surname>Soininen</surname><given-names>R</given-names></name><name><surname>Trygvasson</surname><given-names>K</given-names></name><name><surname>Kleeberger</surname><given-names>SR</given-names></name><etal/></person-group><year>2007</year><article-title>Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II</article-title><source>J Clin Invest</source><volume>117</volume><fpage>757</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">17332894</pub-id></citation></ref><ref id="b15-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Haese</surname><given-names>A</given-names></name><name><surname>Wuyts</surname><given-names>A</given-names></name><name><surname>Dillen</surname><given-names>C</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name><name><surname>Billiau</surname><given-names>A</given-names></name><name><surname>Heremans</surname><given-names>H</given-names></name><etal/></person-group><year>2000</year><article-title>In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse</article-title><source>J Interferon Cytokine Res</source><volume>20</volume><issue>7</issue><fpage>667</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">10926210</pub-id></citation></ref><ref id="b16-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>RB</given-names></name><name><surname>McDonnell</surname><given-names>WF</given-names></name><name><surname>Mann</surname><given-names>R</given-names></name><name><surname>Becker</surname><given-names>S</given-names></name><name><surname>House</surname><given-names>DE</given-names></name><name><surname>Schreinemachers</surname><given-names>D</given-names></name><etal/></person-group><year>1991</year><article-title>Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung</article-title><source>Am J Respir Cell Mol Biol</source><volume>4</volume><issue>1</issue><fpage>72</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">1846079</pub-id></citation></ref><ref id="b17-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunsmore</surname><given-names>SE</given-names></name><name><surname>Saarialho-Kere</surname><given-names>UK</given-names></name><name><surname>Roby</surname><given-names>JD</given-names></name><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Matrisian</surname><given-names>LM</given-names></name><name><surname>Welgus</surname><given-names>HG</given-names></name><etal/></person-group><year>1998</year><article-title>Matrilysin expression and function in airway epithelium</article-title><source>J Clin Invest</source><volume>102</volume><issue>7</issue><fpage>1321</fpage><lpage>1331</lpage><pub-id pub-id-type="pmid">9769324</pub-id></citation></ref><ref id="b18-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elkington</surname><given-names>PT</given-names></name><name><surname>Friedland</surname><given-names>JS</given-names></name></person-group><year>2006</year><article-title>Matrix metalloproteinases in destructive pulmonary pathology</article-title><source>Thorax</source><volume>61</volume><issue>3</issue><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">16227332</pub-id></citation></ref><ref id="b19-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>Y</given-names></name><name><surname>Ishizaki</surname><given-names>M</given-names></name><name><surname>Kudoh</surname><given-names>S</given-names></name><name><surname>Kitaichi</surname><given-names>M</given-names></name><name><surname>Yamanaka</surname><given-names>N</given-names></name></person-group><year>1998</year><article-title>Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases</article-title><source>Lab Invest</source><volume>78</volume><issue>6</issue><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">9645759</pub-id></citation></ref><ref id="b20-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goetzl</surname><given-names>EJ</given-names></name><name><surname>Banda</surname><given-names>MJ</given-names></name><name><surname>Leppert</surname><given-names>D</given-names></name></person-group><year>1996</year><article-title>Matrix metalloproteinases in immunity</article-title><source>J Immunol</source><volume>156</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8598448</pub-id></citation></ref><ref id="b21-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>RA</given-names></name><name><surname>Mizgerd</surname><given-names>JP</given-names></name><name><surname>Shore</surname><given-names>SA</given-names></name></person-group><year>2005a</year><article-title>CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>288</volume><issue>1</issue><fpage>L61</fpage><lpage>L67</lpage><pub-id pub-id-type="pmid">15361358</pub-id></citation></ref><ref id="b22-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>RA</given-names></name><name><surname>Schwartzman</surname><given-names>IN</given-names></name><name><surname>Flynt</surname><given-names>L</given-names></name><name><surname>Shore</surname><given-names>SA</given-names></name></person-group><year>2005b</year><article-title>Role of interleukin-6 in murine airway responses to ozone</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>288</volume><issue>2</issue><fpage>L390</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">15516495</pub-id></citation></ref><ref id="b23-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>EA</given-names></name><name><surname>Busse</surname><given-names>WW</given-names></name><name><surname>Jarjour</surname><given-names>NN</given-names></name></person-group><year>2000</year><article-title>Increased matrix metalloproteinase-9 in the airway after allergen challenge</article-title><source>Am J Respir Crit Care Med</source><volume>162</volume><issue>3 Pt 1</issue><fpage>1157</fpage><lpage>1161</lpage><pub-id pub-id-type="pmid">10988146</pub-id></citation></ref><ref id="b24-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kenyon</surname><given-names>NJ</given-names></name><name><surname>van der Vliet</surname><given-names>A</given-names></name><name><surname>Schock</surname><given-names>BC</given-names></name><name><surname>Okamoto</surname><given-names>T</given-names></name><name><surname>McGrew</surname><given-names>GM</given-names></name><name><surname>Last</surname><given-names>JA</given-names></name></person-group><year>2002</year><article-title>Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>282</volume><issue>3</issue><fpage>L540</fpage><lpage>L545</lpage><pub-id pub-id-type="pmid">11839550</pub-id></citation></ref><ref id="b25-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kheradmand</surname><given-names>F</given-names></name><name><surname>Rishi</surname><given-names>K</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name></person-group><year>2002</year><article-title>Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2</article-title><source>J Cell Sci</source><volume>115</volume><issue>Pt 4</issue><fpage>839</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">11865039</pub-id></citation></ref><ref id="b26-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleeberger</surname><given-names>SR</given-names></name><name><surname>Levitt</surname><given-names>RC</given-names></name><name><surname>Zhang</surname><given-names>L-Y</given-names></name></person-group><year>1993</year><article-title>Susceptibility to ozone-induced inflammation. I. Genetic control of the response to subacute exposure</article-title><source>Am J Physiol</source><volume>264</volume><issue>1 pt 1</issue><fpage>L15</fpage><lpage>L20</lpage><pub-id pub-id-type="pmid">8430812</pub-id></citation></ref><ref id="b27-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleeberger</surname><given-names>SR</given-names></name><name><surname>Levitt</surname><given-names>RC</given-names></name><name><surname>Zhang</surname><given-names>LY</given-names></name><name><surname>Longphre</surname><given-names>M</given-names></name><name><surname>Harkema</surname><given-names>J</given-names></name><name><surname>Jedlicka</surname><given-names>A</given-names></name><etal/></person-group><year>1997</year><article-title>Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice</article-title><source>Nat Genet</source><volume>17</volume><issue>4</issue><fpage>475</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">9398854</pub-id></citation></ref><ref id="b28-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koren</surname><given-names>HS</given-names></name><name><surname>Devlin</surname><given-names>RB</given-names></name><name><surname>Graham</surname><given-names>DE</given-names></name><name><surname>Mann</surname><given-names>R</given-names></name><name><surname>McGee</surname><given-names>MP</given-names></name><name><surname>Horstman</surname><given-names>DH</given-names></name><etal/></person-group><year>1989</year><article-title>Ozone-induced inflammation in the lower airways of human subjects</article-title><source>Am Rev Respir Dis</source><volume>139</volume><issue>2</issue><fpage>407</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">2913889</pub-id></citation></ref><ref id="b29-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>MT</given-names></name><name><surname>Madden</surname><given-names>J</given-names></name><name><surname>Teran</surname><given-names>LM</given-names></name><name><surname>Biscione</surname><given-names>GL</given-names></name><name><surname>Lau</surname><given-names>LC</given-names></name><name><surname>Withers</surname><given-names>NJ</given-names></name><etal/></person-group><year>1998</year><article-title>Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects</article-title><source>Eur Respir J</source><volume>11</volume><issue>6</issue><fpage>1294</fpage><lpage>1300</lpage><pub-id pub-id-type="pmid">9657569</pub-id></citation></ref><ref id="b30-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanchou</surname><given-names>J</given-names></name><name><surname>Corbel</surname><given-names>M</given-names></name><name><surname>Tanguy</surname><given-names>M</given-names></name><name><surname>Germain</surname><given-names>N</given-names></name><name><surname>Boichot</surname><given-names>E</given-names></name><name><surname>Theret</surname><given-names>N</given-names></name><etal/></person-group><year>2003</year><article-title>Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients</article-title><source>Crit Care Med</source><volume>31</volume><issue>2</issue><fpage>536</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">12576963</pub-id></citation></ref><ref id="b31-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanone</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>CG</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><etal/></person-group><year>2002</year><article-title>Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling</article-title><source>J Clin Invest</source><volume>110</volume><issue>4</issue><fpage>463</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">12189240</pub-id></citation></ref><ref id="b32-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laskin</surname><given-names>DL</given-names></name><name><surname>Fakhrzadeh</surname><given-names>L</given-names></name><name><surname>Heck</surname><given-names>DE</given-names></name><name><surname>Gerecke</surname><given-names>D</given-names></name><name><surname>Laskin</surname><given-names>JD</given-names></name></person-group><year>2002</year><article-title>Upregulation of phosphoinositide 3-kinase and protein kinase B in alveolar macrophages following ozone inhalation. Role of NF-kappaB and STAT-1 in ozone-induced nitric oxide production and toxicity</article-title><source>Mol Cell Biochem</source><volume>234&#x02013;235</volume><issue>1&#x02013;2</issue><fpage>91</fpage><lpage>98</lpage></citation></ref><ref id="b33-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemjabbar</surname><given-names>H</given-names></name><name><surname>Gosset</surname><given-names>P</given-names></name><name><surname>Lamblin</surname><given-names>C</given-names></name><name><surname>Tillie</surname><given-names>I</given-names></name><name><surname>Hartmann</surname><given-names>D</given-names></name><name><surname>Wallaert</surname><given-names>B</given-names></name><etal/></person-group><year>1999a</year><article-title>Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus</article-title><source>Am J Respir Crit Care Med</source><volume>159</volume><issue>4 pt 1</issue><fpage>1298</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">10194181</pub-id></citation></ref><ref id="b34-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemjabbar</surname><given-names>H</given-names></name><name><surname>Gosset</surname><given-names>P</given-names></name><name><surname>Lechapt-Zalcman</surname><given-names>E</given-names></name><name><surname>Franco-Montoya</surname><given-names>ML</given-names></name><name><surname>Wallaert</surname><given-names>B</given-names></name><name><surname>Harf</surname><given-names>A</given-names></name><etal/></person-group><year>1999b</year><article-title>Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment</article-title><source>Am J Respir Cell Mol Biol</source><volume>20</volume><issue>5</issue><fpage>903</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">10226060</pub-id></citation></ref><ref id="b35-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Park</surname><given-names>PW</given-names></name><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Parks</surname><given-names>WC</given-names></name></person-group><year>2002</year><article-title>Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury</article-title><source>Cell</source><volume>111</volume><issue>5</issue><fpage>635</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">12464176</pub-id></citation></ref><ref id="b36-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mautino</surname><given-names>G</given-names></name><name><surname>Oliver</surname><given-names>N</given-names></name><name><surname>Chanez</surname><given-names>P</given-names></name><name><surname>Bousquet</surname><given-names>J</given-names></name><name><surname>Capony</surname><given-names>F</given-names></name></person-group><year>1997</year><article-title>Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics</article-title><source>Am J Respir Cell Mol Biol</source><volume>17</volume><issue>5</issue><fpage>583</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">9374109</pub-id></citation></ref><ref id="b37-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McQuibban</surname><given-names>GA</given-names></name><name><surname>Gong</surname><given-names>JH</given-names></name><name><surname>Tam</surname><given-names>EM</given-names></name><name><surname>McCulloch</surname><given-names>CA</given-names></name><name><surname>Clark-Lewis</surname><given-names>I</given-names></name><name><surname>Overall</surname><given-names>CM</given-names></name></person-group><year>2000</year><article-title>Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3</article-title><source>Science</source><volume>289</volume><issue>5482</issue><fpage>1202</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">10947989</pub-id></citation></ref><ref id="b38-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>MJ</given-names></name><name><surname>Seaton</surname><given-names>T</given-names></name><name><surname>Mitchell</surname><given-names>J</given-names></name><name><surname>Howe</surname><given-names>A</given-names></name><name><surname>Blackburn</surname><given-names>K</given-names></name><name><surname>Burkhart</surname><given-names>W</given-names></name><etal/></person-group><year>2002</year><article-title>The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity</article-title><source>Biochemistry</source><volume>41</volume><issue>30</issue><fpage>9462</fpage><lpage>9469</lpage><pub-id pub-id-type="pmid">12135369</pub-id></citation></ref><ref id="b39-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>R</given-names></name><name><surname>Chintala</surname><given-names>SK</given-names></name><name><surname>Jung</surname><given-names>JC</given-names></name><name><surname>Villar</surname><given-names>WV</given-names></name><name><surname>McCabe</surname><given-names>F</given-names></name><name><surname>Russo</surname><given-names>LA</given-names></name><etal/></person-group><year>2002</year><article-title>Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration</article-title><source>J Biol Chem</source><volume>277</volume><issue>3</issue><fpage>2065</fpage><lpage>2072</lpage><pub-id pub-id-type="pmid">11689563</pub-id></citation></ref><ref id="b40-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagase</surname><given-names>H</given-names></name><name><surname>Woessner</surname><given-names>JF</given-names><suffix>Jr</suffix></name></person-group><year>1999</year><article-title>Matrix metalloproteinases</article-title><source>J Biol Chem</source><volume>274</volume><issue>31</issue><fpage>21491</fpage><lpage>21494</lpage><pub-id pub-id-type="pmid">10419448</pub-id></citation></ref><ref id="b41-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>A</given-names></name><name><surname>Barrios</surname><given-names>R</given-names></name><name><surname>Maldonado</surname><given-names>V</given-names></name><name><surname>Melendez</surname><given-names>J</given-names></name><name><surname>Perez</surname><given-names>J</given-names></name><name><surname>Ruiz</surname><given-names>V</given-names></name><etal/></person-group><year>1998</year><article-title>Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications</article-title><source>Am J Pathol</source><volume>153</volume><issue>3</issue><fpage>833</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">9736032</pub-id></citation></ref><ref id="b42-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>WC</given-names></name><name><surname>Shapiro</surname><given-names>SD</given-names></name></person-group><year>2001</year><article-title>Matrix metalloproteinases in lung biology</article-title><source>Respir Res</source><volume>2</volume><issue>1</issue><fpage>10</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">11686860</pub-id></citation></ref><ref id="b43-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>WC</given-names></name><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Lopez-Boado</surname><given-names>YS</given-names></name></person-group><year>2004</year><article-title>Matrix metalloproteinases as modulators of inflammation and innate immunity</article-title><source>Nat Rev Immunol</source><volume>4</volume><issue>8</issue><fpage>617</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">15286728</pub-id></citation></ref><ref id="b44-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez-Ramos</surname><given-names>J</given-names></name><name><surname>Segura-Valdez</surname><given-names>MD</given-names></name><name><surname>Vanda</surname><given-names>B</given-names></name><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Pardo</surname><given-names>A</given-names></name></person-group><year>1999</year><article-title>Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis</article-title><source>Am J Respir Crit Care Med</source><volume>160</volume><fpage>1274</fpage><lpage>1282</lpage><pub-id pub-id-type="pmid">10508819</pub-id></citation></ref><ref id="b45-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>RE</given-names></name><name><surname>Culpitt</surname><given-names>SV</given-names></name><name><surname>DeMatos</surname><given-names>C</given-names></name><name><surname>Donnelly</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Wiggins</surname><given-names>J</given-names></name><etal/></person-group><year>2002</year><article-title>Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease</article-title><source>Am J Respir Cell Mol Biol</source><volume>26</volume><issue>5</issue><fpage>602</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">11970913</pub-id></citation></ref><ref id="b46-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schelegle</surname><given-names>ES</given-names></name><name><surname>Siefkin</surname><given-names>AD</given-names></name><name><surname>McDonald</surname><given-names>RJ</given-names></name></person-group><year>1991</year><article-title>Time course of ozone-induced neutrophilia in normal humans</article-title><source>Am Rev Respir Dis</source><volume>143</volume><issue>6</issue><fpage>1353</fpage><lpage>1358</lpage><pub-id pub-id-type="pmid">2048824</pub-id></citation></ref><ref id="b47-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schonbeck</surname><given-names>U</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name></person-group><year>1998</year><article-title>Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing</article-title><source>J Immunol</source><volume>161</volume><issue>7</issue><fpage>3340</fpage><lpage>3346</lpage><pub-id pub-id-type="pmid">9759850</pub-id></citation></ref><ref id="b48-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seltzer</surname><given-names>J</given-names></name><name><surname>Bigby</surname><given-names>BG</given-names></name><name><surname>Stulbarg</surname><given-names>M</given-names></name><name><surname>Holtzman</surname><given-names>MJ</given-names></name><name><surname>Nadel</surname><given-names>JA</given-names></name><name><surname>Ueki</surname><given-names>IF</given-names></name><etal/></person-group><year>1986</year><article-title>O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans</article-title><source>J Appl Physiol</source><volume>60</volume><issue>4</issue><fpage>1321</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">3084448</pub-id></citation></ref><ref id="b49-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sternlicht</surname><given-names>MD</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name></person-group><year>2001</year><article-title>How matrix metalloproteinases regulate cell behavior</article-title><source>Annu Rev Cell Dev Biol</source><volume>17</volume><fpage>463</fpage><lpage>516</lpage><pub-id pub-id-type="pmid">11687497</pub-id></citation></ref><ref id="b50-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>RJ</given-names></name><name><surname>Fattman</surname><given-names>CL</given-names></name><name><surname>Niehouse</surname><given-names>LM</given-names></name><name><surname>Tobolewski</surname><given-names>JM</given-names></name><name><surname>Hanford</surname><given-names>LE</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><etal/></person-group><year>2006</year><article-title>Matrix metalloproteinases promoted inflammation and fibrosis in asbestosis-induced lung injury in mice</article-title><source>Am J Respir Cell Mol Biol</source><volume>35</volume><fpage>289</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">16574944</pub-id></citation></ref><ref id="b51-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valacchi</surname><given-names>G</given-names></name><name><surname>Pagnin</surname><given-names>E</given-names></name><name><surname>Okamoto</surname><given-names>T</given-names></name><name><surname>Corbacho</surname><given-names>AM</given-names></name><name><surname>Olano</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>PA</given-names></name><etal/></person-group><year>2003</year><article-title>Induction of stress proteins and MMP-9 by 0.8 ppm of ozone in murine skin</article-title><source>Biochem Biophys Res Commun</source><volume>305</volume><issue>3</issue><fpage>741</fpage><lpage>746</lpage><pub-id pub-id-type="pmid">12763055</pub-id></citation></ref><ref id="b52-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van den Steen</surname><given-names>PE</given-names></name><name><surname>Proost</surname><given-names>P</given-names></name><name><surname>Wuyts</surname><given-names>A</given-names></name><name><surname>Van Damme</surname><given-names>J</given-names></name><name><surname>Opdenakker</surname><given-names>G</given-names></name></person-group><year>2000</year><article-title>Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact</article-title><source>Blood</source><volume>96</volume><issue>8</issue><fpage>2673</fpage><lpage>2681</lpage><pub-id pub-id-type="pmid">11023497</pub-id></citation></ref><ref id="b53-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visse</surname><given-names>R</given-names></name><name><surname>Nagase</surname><given-names>H</given-names></name></person-group><year>2003</year><article-title>Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry</article-title><source>Circ Res</source><volume>92</volume><issue>8</issue><fpage>827</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">12730128</pub-id></citation></ref><ref id="b54-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Matrisian</surname><given-names>LM</given-names></name></person-group><year>1996</year><article-title>Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions</article-title><source>Int J Biochem Cell Biol</source><volume>28</volume><issue>2</issue><fpage>123</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">8729000</pub-id></citation></ref><ref id="b55-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Stamenkovic</surname><given-names>I</given-names></name></person-group><year>2000</year><article-title>Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis</article-title><source>Genes Dev</source><volume>14</volume><issue>2</issue><fpage>163</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">10652271</pub-id></citation></ref><ref id="b56-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>McQuibban</surname><given-names>GA</given-names></name><name><surname>Silva</surname><given-names>C</given-names></name><name><surname>Butler</surname><given-names>GS</given-names></name><name><surname>Johnston</surname><given-names>JB</given-names></name><name><surname>Holden</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration</article-title><source>Nat Neurosci</source><volume>6</volume><issue>10</issue><fpage>1064</fpage><lpage>1071</lpage><pub-id pub-id-type="pmid">14502291</pub-id></citation></ref><ref id="b57-ehp0115-001557"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>F</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Eugui</surname><given-names>E</given-names></name><name><surname>Allard</surname><given-names>J</given-names></name><name><surname>Yakhini</surname><given-names>Z</given-names></name><name><surname>Ben-Dor</surname><given-names>A</given-names></name><etal/></person-group><year>2002</year><article-title>Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans</article-title><source>Proc Natl Acad Sci USA</source><volume>99</volume><issue>9</issue><fpage>6292</fpage><lpage>6297</lpage><pub-id pub-id-type="pmid">11983918</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="f1-ehp0115-001557" position="float"><label>Figure 1</label><caption><p>Concentration of total protein (<italic>A</italic>) and numbers of neutrophils (<italic>B</italic>) and epithelial cells (<italic>C</italic>) in BALF recovered from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;</sup><italic><sup>/</sup></italic><sup>&#x02212;</sup> mice after exposure to 0.3 ppm O<sub>3</sub> or filtered air. Data are presented as means &#x000b1; SE (<italic>n</italic> = 8&#x02013;10/group).</p><p>*Significantly different from genotype-matched air control mice (<italic>p</italic> &#x0003c; 0.05). <sup>#</sup>Significantly different from exposure-matched <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<italic>p</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="ehp0115-001557f1"/></fig><fig id="f2-ehp0115-001557" position="float"><label>Figure 2</label><caption><p>MMP-9 mRNA, protein, and activity after exposure to 0.3 ppm O<sub>3</sub> or filtered air. (<italic>A</italic>) Representative images of MMP-9 activity in BALF from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice determined by gelatin zymogram after exposure to 0.3 ppm O<sub>3</sub> (24, 48, 72 hr) or filtered air (<italic>n</italic> = 3/group). (<italic>B</italic>) Representative Western blots of MMP-9 in pooled lung homogenates from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> (+/+) and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> (&#x02212;/&#x02212;) mice after exposure to 0.3 ppm O<sub>3</sub> (24, 48, 72 hr) or filtered air (<italic>n</italic> = 3/group). (<italic>C</italic>) MMP-9 mRNA expression in lung homogenates from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice after exposure to 0.3 ppm O<sub>3</sub> (6, 24, 48 hr) or filtered air. Quantitative real-time PCR-determined fold increase of normalized expression to 18s rRNA compared with air-exposed mice (<italic>n</italic> = 3/group). Data are presented as means &#x000b1; SE.</p><p>*Significantly different from air control mice (<italic>p</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="ehp0115-001557f2"/></fig><fig id="f3-ehp0115-001557" position="float"><label>Figure 3</label><caption><p>Immunohistochemical localization of MMP-9 in the lungs of <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice after filtered air (<italic>A</italic>) and 48-hr O<sub>3</sub> (<italic>B,C,D</italic>) exposure. Representative light micrographs at higher magnifications (<italic>D</italic>) show MMP-9&#x02013;positive cells (in brown) including alveolar epithelial cells, infiltrating inflammatory cells, myofibroblasts, and cells in the injured regions undergoing proliferation and differentiation. Lung tissue sections from <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice exposed to O<sub>3</sub> (<italic>E</italic>) were similarly processed and visualized as negative controls. Abbreviations: av, alveoli; bv, blood vessels; tb, terminal bronchioles. Bars = 50 &#x003bc;m.</p></caption><graphic xlink:href="ehp0115-001557f3"/></fig><fig id="f4-ehp0115-001557" position="float"><label>Figure 4</label><caption><p>Measurement of MMP-2 in BALF and lung protein extracts from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice after exposure to filtered air or 0.3 ppm O<sub>3</sub>. (<italic>A</italic>) Representative Western blot image of MMP-2 protein expression in pooled lung homogenates from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> (+/+) and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> (&#x02212;/&#x02212;) mice after exposure to 0.3 ppm O<sub>3</sub> (24, 48, 72 hr) or filtered air (<italic>n</italic> = 3/group). (<italic>B</italic>) Representative gelatin zymogram image for MMP-2 activity in BALF from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> (+/+) and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> (&#x02212;/&#x02212;) mice after exposure to 0.3 ppm O<sub>3</sub> (48 hr) or filtered air. Relative optical density of MMP-2 activity quantified from zymogram blots. Data are presented as means &#x000b1; SE (<italic>n</italic> = 3/group). </p><p>*Significantly different from genotype-matched air control mice (<italic>p</italic> &#x0003c; 0.05). <sup>#</sup>Significantly different from O<sub>3</sub> (48 hr)-exposed <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<italic>p</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="ehp0115-001557f4"/></fig><fig id="f5-ehp0115-001557" position="float"><label>Figure 5</label><caption><p>Lung histology from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> (<italic>A,B</italic>) and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> (<italic>C,D</italic>) mice exposed to air (<italic>A,C</italic>) and 48 hr O<sub>3</sub> (<italic>B,D</italic>). Paraffin-embedded left lung tissue sections were stained with H&#x00026;E for histopathologic analysis. Representative light micrographs show more severe epithelial thickening, inflammation, and alveolar vacuolization in distal airways of <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>D</italic>) relative to those of <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<italic>B</italic>) exposed to O<sub>3</sub>. Abbreviations: av, alveoli; bv, blood vessels; tb, terminal bronchioles. Bars = 100 &#x003bc;m.</p></caption><graphic xlink:href="ehp0115-001557f5"/></fig><fig id="f6-ehp0115-001557" position="float"><label>Figure 6</label><caption><p>Cell proliferation in lungs of <italic>Mmp9</italic><italic><sup>+/+</sup></italic> (<italic>A,B</italic>) and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> (<italic>C,D</italic>) mice exposed to air (<italic>A,C</italic>) and 48 hr O<sub>3</sub> (<italic>B,D</italic>). Ki-67&#x02013;positive cells in G/S phases of the cell cycle were detected immunohistochemically, and representative light photomicrographs display nuclear localization of Ki-67 (brown dots) in cells of severely injured terminal bronchioles. Abbreviations: av, alveoli; bv, blood vessels; tb, terminal bronchioles. Bars = 50 &#x003bc;m.</p></caption><graphic xlink:href="ehp0115-001557f6"/></fig><fig id="f7-ehp0115-001557" position="float"><label>Figure 7</label><caption><p>Protein levels of neutrophil chemokines KC (<italic>A</italic>) and MIP-2 (<italic>B</italic>) in BALF from <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice exposed to air and 0.3 ppm O<sub>3</sub>. Data are presented as means &#x000b1; SE (<italic>n</italic> = 7&#x02013;8/group). </p><p>*Significantly different from genotype-matched air control mice (<italic>p</italic> &#x0003c; 0.05). <sup>#</sup>Significantly different from exposure-matched <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<italic>p</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="ehp0115-001557f7"/></fig><fig id="f8-ehp0115-001557" position="float"><label>Figure 8</label><caption><p>mRNA expression of neutrophilic chemokines KC (<italic>A</italic>) and MIP-2 (<italic>B</italic>) in <italic>Mmp9</italic><italic><sup>+/+</sup></italic> and <italic>Mmp9</italic><sup>&#x02212;/&#x02212;</sup> mice exposed to air and 0.3 ppm O<sub>3</sub>. Quantitative real time PCR determined fold increase of message expression normalized to18s rRNA compared with air exposed <italic>Mmp9</italic><italic><sup>+/+</sup></italic> mice (<italic>n</italic> = 3/group). Data are presented as means &#x000b1; SE (<italic>n</italic> = 3/group).</p><p>*Significantly different from genotype-matched air control mice (<italic>p</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="ehp0115-001557f8"/></fig><table-wrap id="t1-ehp0115-001557" position="float"><label>Table 1</label><caption><p>Effect of <italic>Mmp7</italic> deficiency on BALF protein and cell differentials after O<sub>3</sub> exposure (0.3 ppm for 48 hr).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Genotype</th><th align="center" rowspan="1" colspan="1">Proteins (&#x003bc;g/mL)</th><th align="center" rowspan="1" colspan="1">Macrophages (&#x000d7;10<sup>3</sup>/mL)</th><th align="center" rowspan="1" colspan="1">Neutrophils (&#x000d7;10<sup>3</sup>/mL)</th><th align="center" rowspan="1" colspan="1">Epithelial cells (&#x000d7;10<sup>3</sup>/mL)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Mmp7</italic><sup>+/+</sup> (Air)</td><td align="center" rowspan="1" colspan="1">107.0 &#x000b1; 6.7</td><td align="center" rowspan="1" colspan="1">21.8 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">0.1 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">1.7 &#x000b1; 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup> (Air)</td><td align="center" rowspan="1" colspan="1">140.0 &#x000b1; 4.7</td><td align="center" rowspan="1" colspan="1">23.5 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">0.02 &#x000b1; 0.02</td><td align="center" rowspan="1" colspan="1">1.5 &#x000b1; 0.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Mmp7</italic><sup>+/+</sup> (O<sub>3</sub>)</td><td align="center" rowspan="1" colspan="1">540.8 &#x000b1; 32.1<xref ref-type="table-fn" rid="tfn2-ehp0115-001557">*</xref></td><td align="center" rowspan="1" colspan="1">47.6 &#x000b1; 2.2<xref ref-type="table-fn" rid="tfn2-ehp0115-001557">*</xref></td><td align="center" rowspan="1" colspan="1">5.9 &#x000b1; 1.5<xref ref-type="table-fn" rid="tfn2-ehp0115-001557">*</xref></td><td align="center" rowspan="1" colspan="1">3.0 &#x000b1; 0.5</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Mmp7</italic><sup>&#x02212;/&#x02212;</sup> (O<sub>3</sub>)</td><td align="center" rowspan="1" colspan="1">707.5 &#x000b1; 73.1<xref ref-type="table-fn" rid="tfn2-ehp0115-001557">*</xref></td><td align="center" rowspan="1" colspan="1">49.7 &#x000b1; 4.4<xref ref-type="table-fn" rid="tfn2-ehp0115-001557">*</xref></td><td align="center" rowspan="1" colspan="1">10.0 &#x000b1; 3.3<xref ref-type="table-fn" rid="tfn2-ehp0115-001557">*</xref></td><td align="center" rowspan="1" colspan="1">7.1 &#x000b1; 1.2<xref ref-type="table-fn" rid="tfn2-ehp0115-001557">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ehp0115-001557"><p>Results are the means &#x000b1; SE for 5&#x02013;8 mice in each group.</p></fn><fn id="tfn2-ehp0115-001557"><label>*</label><p>Significantly different from genotype-matched air control mice (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 